Obesity has been an
ongoing problem in modern America, growing as the years proceed. In fact, more
than one-third of all adults in the United States are obese, leading to higher
risk of heart attack, diabetes, stroke, and even cancer. Unfortunately, despite
various weight loss programs and changes in lifestyle, many people have not
been able to lose weight. Fortunately, the Food and Drug Administration as
recently approved a new and unique weight loss treatment: the Maestro
Rechargeable System.
Through
the Maestro Rechargeable System, patients have electrodes surgically implanted
into their abdomen. The system works by sending electrical impulses to the
vagus nerve in the abdomen, which is involved in signaling the brain to indicate hunger. The system is even equipped with adjustable
settings so that physicians can provide the best, most personalized treatment
to each person. To ensure the safety of this treatment, the manufacturers are
conducting a five-year post-approval study where they will monitor 100 patients
and collect the effectiveness and safety data. While there are side effects,
such as nausea, pain, vomiting, and surgical complications, this revolutionary
new treatment could help us combat obesity in a more effective way than ever
before.
U.S. Food and Drug Administration. "FDA approves first-of-kind device to treat obesity." ScienceDaily. ScienceDaily, 29 January 2015. .
Posts
